Search
Showing results for "1"
Exploring the link between diabetes and mental health. Story by The West Australian featuring Dr Keely Bebbington.
Did you catch the kids’ takeover Telethon segment on the weekend? If so, you may have spied James Fernihough hanging out with Ch 7 television personality Andrew Denton in the The Kids Discovery Centre.
Kids living with Type 1 Diabetes got to hang out with super heroes and like-minded peers at the Diabetes WA and Princess Margaret Hospital (now known as Perth Children’s Hospital) kids’ camp in Bicton recently.
Congratulations to Dr Vinutha Shetty who has been awarded a Type 1 Diabetes Clinical Research Network’s Mentored Clinician Researcher Fellowship Award for 2017.
Despite the unseasonal weather, good turnouts were recorded for recent events organised by PMH and Diabetes WA.
The pivotal phase 3 EPITOPE trial, a 12-month, double-blind, placebo-controlled study of epicutaneous immunotherapy with the VIASKIN patch containing 250 μg of peanut protein (VP250), previously reported significant treatment response versus placebo in peanut-allergic toddlers aged 1 through 3 years.
Immune checkpoint blockade (ICB) evokes antitumor immunity through the reinvigoration of T cell responses. T cell differentiation status controls response, with less differentiated cells having an enhanced capacity to proliferate after ICB. Given that conventional type 1 dendritic cells (cDC1) maintain precursor exhausted T cells (TPEX), we hypothesized that expansion of cDC1s with Flt3L could enhance responses to ICB.
Tim Jones MBBS DCH FRACP MD Co-head, Diabetes and Obesity Research Co-head, Diabetes and Obesity Research Areas of research expertise: Diabetes
Investigators: Anna Hunt, Ashleigh Lin Stress and anxiety are significant problems in children and adolescence with type 1 diabetes. Not only do
Understanding immunity in humans to Group A Streptococcus (Strep A) is critical for the development of successful vaccines to prevent the morbidity and mortality attributed to Strep A infections. Despite decades of effort, no licensed vaccine against Strep A exists and immune correlates of protection are lacking; a major impediment to vaccine development.